Secretion of Extracellular Superoxide Dismutase From Muscle Transduced With Recombinant Adenovirus Inhibits the Growth of B16 Melanomas in Mice

Molecular Cancer Research

Volumn 1, Issue 12, 2003, Pages 871-881

  Wheeler, Michael D ^a,b   Smutney, Olivia M ^a   Jude Samulski, R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD31 ANTIGEN; EXTRACELLULAR SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME RELEASE; GROWTH INHIBITION; IMPLANTATION; MELANOMA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME; VIRUS INHIBITION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CATALASE; CELL LINE, TUMOR; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GLUTATHIONE PEROXIDASE; IMMUNOHISTOCHEMISTRY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OXIDATIVE STRESS; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSDUCTION, GENETIC; UP-REGULATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0142120588     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. American Cancer Society. Nutrition and cancer: causation and prevention. An American Cancer Society special report. CA Cancer J. Clin., 34: 5-10, 1984.
2. Stahl, W. and Sies, H. Lycopene: a biologically important carotenoid for humans? Arch. Biochem. Biophys., 336: 1-9, 1996.
3. Weisburger, J. H. Prevention of cancer and other chronic diseases worldwide based on sound mechanisms. BioFactors, 12: 73-81, 2000.
4. Ambrosone, C. B. Oxidants and antioxidants in breast cancer. Antioxid. Redox Signal., 2: 903-917, 2000
5. Mathers, J. C. Dietary strategies to reduce the burden of cancer and cardiovascular disease in the UK. Br. J. Nutr., 84 (Suppl. 2): S211-S216, 2000.
6. Giovannucci, E. Nutritional factors in human cancers. Adv. Exp. Med. Biol., 472: 29-42, 1999.
7. Griswold, D. P. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents. Cancer Chemother. Rep., 3: 315-324, 1972.
8. Green, E. L. Handbook of Genetically Standardized JAX Mice. Bar Harbor, ME: Bar Harbor Times Publishing Company, 1962.
9. Hagmar, B. and Norby, K. Influence of cultivation, trypsinization and aggregation on the transplantability of melanoma B16 cells. Int. J. Cancer, 11: 663-675, 1973.
10. Rose, M. L., Madren, J., Bunzendahl, H., and Thurman, R. G. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis, 20: 793-798, 1999.
11. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, J., Overholster, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P., and Hicklin, D. J. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res., 59: 5209-5218, 1999.
12. 2 in rat heart endothelial cells. Free Radic. Biol. Med., 25: 891-897, 1998.
13. Redondo, P., Bandres, E., Solano, T., Okroujnov, I., and Garcia-Foncillas, J. Vascular endothelial growth factor (VEGF) and melanoma. N-acetylcysteine downregulates VEGF production in vitro. Cytokine, 12: 374-378, 2000.
14. Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., and Lambeth, L. D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA, 99: 715-720, 2002.
15. Konopka, T. E., Barker, J. E., Bamford, T. L., Guida, E., Anderson, R. L., and Stewart, A. G. NOSII gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res., 61: 3182-3187, 2002.
16. Wosko, T. J., Ferrara, D. T., and Sartori, L. S. Histological comparison of the B16 melanoma and its F1 variant. Cancer Lett., 24: 57-63, 1984.
17. Kuroki, M., Voest, E. E., Amano, S., Beerepoot, L. V., Takashima, S., Tolentino, M., Kim, R. Y., Rohan, R. M., Colby, K. A., Yeo, K. T., and Adamis, A. P. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest., 98: 1667-1675, 1996.
18. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem., 271: 21793-21797, 1996.
19. Folkman, J. Tumor angiogenesis: a possible control point in tumor growth. Ann. Intern. Med., 82: 96-100, 1975.
20. Hlatky, L., Hahnfeldt, P., and Folkman, J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst., 94: 883-893, 2002.
21. Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C., Fletcher, J. A., Hlatky, L., Hahnfeldt, P., Folkman, J., and Kaipainen, A. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Invest., 110: 923-932, 2002.
22. Thomlinson, R. H. and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9: 539-549, 1955.
23. Rofstad, E. K. Hypoxia and reoxygenation in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys., 17: 81-89, 1989.
24. Lyng, H., Sundfor, K., Trope, C., and Rofstad, E. K. Oxygen tension and vascular density in human cervix carcinoma. Br. J. Cancer, 74: 1559-1563, 1996.
25. Gersten, D. M. Control of growth and vascularity of B16 melanoma by syngeneic lymphocytes. Cell Biol. Int. Rep., 4: 407-414, 1980.
26. Shing, Y., Folkman, J., Haudenschild, C., Lund, D., Crum, R., and Klagsbrun, M. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J. Cell. Biochem., 29: 275-287, 1985.
27. Shono, T., Ono, M., Izumi, H., Matsushima, K., Okamoto, T., Kohno, K., and Kuwano, M. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol., 16: 4231-4239, 1996.
28. Liu, Y., Cox, S. R., Morita, T., and Kourembanas, S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res., 77: 638-643, 1995.
29. Forsythe, J. A., Jiang, B-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
30. Factor, V. M., Laskowska, D., Jensen, M. R., Woitach, J. T., Popescu, N. C., and Thorgeirsson, S. S. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc. Natl. Acad. Sci. USA, 97: 2196-2201, 2000.
31. Zwacka, R. M., Dudus, L., Epperly, M. W., Greenberger, J. S., and Engelhardt, J. F. Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis. Hum. Gene Ther., 9: 1381-1386, 1998.
32. Graham, F. L. and Prevec, L. Methods for construction ofadenovirus vectors. Mol. Biotechnol., 3: 207-220, 1995.
33. Fidler, I. J. Selection of successive tumor lines for metastasis. Nature (New Biol.), 242: 148-149, 1973
34. Gibson, M. H. L. and Bertalanffy, F. D. The in vivo cell kinetics of transplantable B16 mouse melanoma. Growth, 36: 263-274, 1972.
35. Simon, S. R. and Ershler, W. B. Hormonal influences on growth of B16 murine melanoma. J. Natl. Cancer Inst., 74: 1085-1088, 1985.
36. Gavrieli, Y., Sherman, Y., and Ben Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
37. Crapo, J. D., McCord, J. M., and Fridovich, I. Preparation and assay of superoxide dismutases. Methods Enzymol., 53: 382-393, 1978.
38. McCord, J. M. and Fridovich, I. The reduction of cytochrome c by milk xanthine oxidase. J. Biol. Chem., 243: 5753-5760, 1968.
39. Aebi, H. Catalase in vitro. Methods Enzymol., 105: 121-126, 1984.
40. Flohe, L. and Günzler, W. A. Glutathione-dependent enzymatic oxidoreduction reactions. In: I. M. Arias and W. B. Jakoby (eds.), Glutathione: Metabolism and Function, pp. 17-34. New York: Raven Press, 1976.
41. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
42. Rusyn, I., Tsukamoto, H., and Thurman, R. G. WY-14,643 rapidly activates nuclear factor κB in Kupffer cells before hepatocytes. Carcinogenesis, 19: 1217-1222, 1998.